Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A deletion of the short arm on human chromosome 1 is a common genetic abnormality in
neuroblastoma
, which is a highly malignant tumor in young childhood. Recently,
calmodulin-binding transcription activator 1
(
CAMTA1
) gene was identified at 1p36 and considered as a candidate tumor suppressor of
neuroblastoma
. In the present study, we demonstrate that the expression levels of
CAMTA1
mRNA were high in N-type
neuroblastoma
cell lines but low in S-type
neuroblastoma
cell lines. This result suggested that
CAMTA1
could associate with the differentiation of
neuroblastoma
cells. Moreover, we examined the relationship between the expression of
CAMTA1
and cell cycle progression in N-type
neuroblastoma
SK-N-SH cells. During cell cycle synchronization, cell cycle phases were checked by flow cytometry and Western blot analysis of cell cycle-related proteins. Then, the expression of
CAMTA1
mRNA was determined by RT-PCR in each phase of the cell cycle.
CAMTA1
mRNA showed a cell cycle-dependent expression, resulting in high levels of expression in S and M phases. Moreover, microscopic analysis revealed that the cell cycle-dependent expression of CAMTA1 protein is in agreement with mRNA expression. Taken together,
CAMTA1
is expressed in S and M phases and decreased in post-mitosis. These results suggest that
CAMTA1
may participate in induction of cell differentiation and cell cycle regulation.
...
PMID:Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells. 1513 81